NM_004224.3:c.469G>T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004224.3(GPR50):c.469G>T(p.Val157Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000711 in 1,209,382 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004224.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111715Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33907
GnomAD3 exomes AF: 0.00000550 AC: 1AN: 181821Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67363
GnomAD4 exome AF: 0.0000765 AC: 84AN: 1097667Hom.: 0 Cov.: 33 AF XY: 0.0000606 AC XY: 22AN XY: 363031
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111715Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33907
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.469G>T (p.V157F) alteration is located in exon 2 (coding exon 2) of the GPR50 gene. This alteration results from a G to T substitution at nucleotide position 469, causing the valine (V) at amino acid position 157 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at